Drug-Eluting Stents (DES) Manufacturers & Factory in Portugal

Pioneering the Next Generation of Vascular Intervention with Advanced Coating Technologies and Precision Engineering for the Portuguese Healthcare Landscape.

The Landscape of Vascular Intervention in Portugal

Portugal has emerged as a significant player in the European medical technology sector, particularly through its Health Cluster Portugal (HCP) initiative. As a leading Drug-Eluting Stents (DES) Manufacturer, we recognize the country's sophisticated healthcare infrastructure, led by the Serviço Nacional de Saúde (SNS). The Portuguese clinical landscape demands high-performance medical devices that meet the rigorous standards of the European Medical Device Regulation (MDR 2017/745).

Cardiovascular health remains a top priority in Porto, Lisbon, and Coimbra, where specialized cardiology units are increasingly adopting minimally invasive Percutaneous Coronary Intervention (PCI) techniques. Our manufacturing processes are aligned with these local needs, providing clinicians with stents that offer superior deliverability and optimized drug-release kinetics.

SJ Medical Factory

Expertise in Drug-Eluting Technology

⚙️

Precision Engineering

Utilizing L605 Cobalt Chromium platforms, our DES systems offer ultra-thin struts (typically 80μm) to minimize vessel injury and accelerate endothelization—a critical factor for the aging population demographic in Portugal.

🧪

Advanced Pharmacology

Our Sirolimus-eluting systems employ biodegradable polymers or polymer-free surfaces to ensure a controlled drug release profile, reducing the risk of late stent thrombosis and improving long-term patient safety in Portuguese clinical trials.

🛡️

Regulatory Compliance

Fully certified with ISO 13485 and CE Marking, our factory operations adhere to the highest European quality standards, ensuring every unit shipped to Portugal is reliable and clinically proven.

5000+ SQM Facility
100k Clean Room Class
25+ Global Partners
10+ Patent Technologies

Industry Trends & Future in the Portuguese Market

Personalized Interventional Cardiology

The trend in Portugal is moving towards personalized medicine. Hospitals like Hospital de Santa Maria in Lisbon are at the forefront of using advanced imaging combined with specialized DES. Our R&D team focuses on developing stents that accommodate complex anatomical variations, such as bifurcations and small vessels, which are prevalent in the Portuguese patient cohort.

  • AI-driven stent design optimization for complex lesions.
  • Development of next-generation bioresorbable scaffolds.
  • Enhanced visibility under fluoroscopy for precision placement.
  • Synergistic therapies combining DES with specialized drug-coated balloons.

Why Partner with our Factory?

As a global DES factory, we provide Portugal-based distributors and healthcare providers with more than just products; we provide a partnership based on trust and innovation.

Hangzhou SJ Medical Co., Ltd. bridge the gap between high-end R&D and affordable healthcare solutions. Our presence in the European market is bolstered by efficient logistics through major ports like Leixões and Sines, ensuring a steady supply chain for Portuguese hospitals.

About Hangzhou SJ Medical Co., Ltd.

Established in 2015, we are dedicated to the research, development, and commercialization of vascular interventional medical devices. Our focus on cardiovascular and peripheral intervention has made us a trusted name for clinicians across Portugal and the European Union.

Manufacturing Excellence

Our modern manufacturing facility operates under strict GMP standards. Featuring a million-class clean workshop with localized hundred-class areas, we ensure that every Drug-Eluting Stent is produced in a sterile, controlled environment. Our technical team, led by industry veterans, utilizes precision balloon forming equipment and laser welding technologies to maintain consistency.

Production Line

Global Certifications & Quality Control

🇪🇺

CE Certified

Full compliance with EU medical device directives for use across Portugal.

📜

ISO 13485

International standard for medical device quality management systems.

🌐

Global Distribution

Exporting to Italy, Spain, France, and the Netherlands with a strong focus on Portugal.

Comprehensive Vascular Portfolio for Portugal

Portugal's Role in Global MedTech Innovation

The strategic position of Portugal as a gateway to the Lusophone world and its strong ties within the European Union make it a vital market for advanced medical devices. Drug-Eluting Stents (DES) produced in our factory are designed to address the increasing incidence of coronary artery disease in Southern Europe. By integrating AI-optimized manufacturing and rigorous testing protocols, we ensure that our products provide the reliability expected by the prestigious medical faculties of Portugal.

Our commitment to the Portuguese market extends beyond product delivery. We provide comprehensive technical support, physician training materials, and efficient after-sales service to ensure that clinical outcomes are maximized. Whether you are a distributor in Lisbon or a procurement officer for a hospital group in the Algarve, our team is ready to deliver world-class interventional solutions tailored to your specific needs.